Cargando…
Simulating the Evolution of Signaling Signatures during CART-Cell – Tumor Cell Interactions
Immunotherapies have been proven to have significant therapeutic efficacy in the treatment of cancer. The last decade has seen adoptive cell therapies, such as chimeric antigen receptor T-cell (CART-cell) therapy, gain FDA approval against specific cancers. Additionally, there are numerous clinical...
Autores principales: | Shah, Viren, Womack, Justin, Zamora, Anthony E., Terhune, Scott S., Dash, Ranjan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cornell University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934731/ https://www.ncbi.nlm.nih.gov/pubmed/36798455 |
Ejemplares similares
-
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity
por: Cox, Michelle J., et al.
Publicado: (2022) -
In vivo CART cell imaging: Paving the way for success in CART cell therapy
por: Sakemura, Reona, et al.
Publicado: (2021) -
Network mechanisms and dysfunction within an integrated computational model of progression through mitosis in the human cell cycle
por: Terhune, Scott S., et al.
Publicado: (2020) -
Crosstalk between Plk1, p53, cell cycle, and G2/M DNA damage checkpoint regulation in cancer: computational modeling and analysis
por: Jung, Yongwoon, et al.
Publicado: (2021) -
Characterization of the Two CART Genes (CART1 and CART2) in Chickens (Gallus gallus)
por: Cai, Guoqing, et al.
Publicado: (2015)